Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes. [electronic resource]
- Clinical pharmacology and therapeutics Aug 2005
- 202-8 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0009-9236
10.1016/j.clpt.2005.04.013 doi
Adult Aged Aged, 80 and over Diabetes Mellitus, Type 2--genetics Female Humans Hypoglycemic Agents--pharmacology Male Middle Aged PPAR gamma--drug effects Polymorphism, Genetic Rosiglitazone Thiazolidinediones--pharmacology